Univ of Pennsylvinia

MyExposome Inc. is an innovative start-up focused on personal environmental monitoring, utilizing passive monitoring devices to help individuals understand their exposure to a variety of environmental chemicals. With locations in Pennsylvania and Oregon, the company aims to make invisible environmental risks visible through advanced technologies like their MyExposome wristbands. These wristbands are designed to detect a range of harmful substances, including pesticides, flame retardants, and polychlorinated biphenyls (PCBs), providing valuable insights into the chemicals present in everyday environments. By equipping users with the ability to monitor their exposure levels, MyExposome empowers individuals to make informed decisions about their health and environment. Generated from the website

Clincierge, based in Philadelphia, PA, offers comprehensive services for clinical trial logistics, specializing in supporting both patients and study sites. With a focus on streamlining travel coordination and enhancing patient experiences, Clincierge aims to optimize trial outcomes by alleviating logistical burdens. The company's dedicated team of Travel Coordinators and CROs work closely with sponsors and sites to ensure seamless trial operations, allowing researchers to concentrate on patient care and study success. Through industry partnerships and a commitment to patient-centric care, Clincierge strives to improve the efficiency and effectiveness of clinical trials.Generated from the website

Trend Community Inc is a digital health analytics company based in Philadelphia, PA. They specialize in transforming the conversations of rare, chronic, and emerging disease communities into actionable insights, supporting community members, healthcare providers, researchers, pharmaceutical sponsors, and regulatory agencies. Their mission is to facilitate understanding, strengthen advocacy, and spark scientific progress. Founded by individuals with personal experiences navigating a rare genetic disorder, Trend Community Inc is not only dedicated to supporting communities but is also an active member within them. Their proprietary evidence-accelerator approach prioritizes the privacy of their communities and aims to provide deeper understanding and actionable insights that can inform drug development, detect unrecognized secondary diagnoses, reveal community-centric lexicons, and ultimately shape the future for those affected by rare, chronic, and emerging diseases.Generated from the website